Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mary Kathleen Buss, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel BJ, Buss MK, Nattam SR, Hurteau J, Luo W, Curtis J, Whalen C, Kohn EC, Ivy SP, Matulonis UA. Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer. Ann Oncol. 2019 Apr; 30(4):551-557. PMID: 31987271.
    Citations:    
  2. Reynolds EE, Buss MK, Schlechter BL. Would You Refer This Patient With Cancer to a Palliative Care Specialist? Ann Intern Med. 2019 09 17; 171(6):448. PMID: 31525741.
    Citations:    
  3. Konstantinopoulos PA, Luo W, Liu JF, Gulhan DC, Krasner C, Ishizuka JJ, Gockley AA, Buss M, Growdon WB, Crowe H, Campos S, Lindeman NI, Hill S, Stover E, Schumer S, Wright AA, Curtis J, Quinn R, Whalen C, Gray KP, Penson RT, Cannistra SA, Fleming GF, Matulonis UA. Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer. J Clin Oncol. 2019 Oct 20; 37(30):2786-2794. PMID: 31461377.
    Citations:    
  4. Finlay E, Newport K, Buss M. Reply to S.A. Bernard et al. J Oncol Pract. 2019 Sep; 15(9):508. PMID: 31369293.
    Citations:    
  5. Sager ZS, Buss MK, Hill KP, Driver JA, Skarf LM. Managing Opioid Use Disorder in the Setting of a Terminal Disease: Opportunities and Challenges. J Palliat Med. 2020 Feb; 23(2):296-299. PMID: 31295046.
    Citations:    
  6. Miranda SP, Schaefer KG, Vates GE, Gormley WB, Buss MK. Palliative Care and Communication Training in Neurosurgery Residency: Results of a Trainee Survey. J Surg Educ. 2019 Nov - Dec; 76(6):1691-1702. PMID: 31239231.
    Citations:    
  7. Bouberhan S, Shea M, Kennedy A, Erlinger A, Stack-Dunnbier H, Buss MK, Moss L, Nolan K, Awtrey C, Dalrymple JL, Garrett L, Liu FW, Hacker MR, Esselen KM. Financial toxicity in gynecologic oncology. Gynecol Oncol. 2019 07; 154(1):8-12. PMID: 31053404.
    Citations:    
  8. Reynolds EE, Buss MK, Schlechter BL, Tess A. Would You Refer This Patient With Cancer to a Palliative Care Specialist?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2019 04 02; 170(7):488-496. PMID: 30934082.
    Citations:    
  9. Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel BJ, Buss MK, Nattam SR, Hurteau J, Luo W, Curtis J, Whalen C, Kohn EC, Ivy SP, Matulonis UA. Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer. Ann Oncol. 2019 04 01; 30(4):551-557. PMID: 30753272.
    Citations:    
  10. Finlay E, Newport K, Sivendran S, Kilpatrick L, Owens M, Buss MK. Models of Outpatient Palliative Care Clinics for Patients With Cancer. J Oncol Pract. 2019 Apr; 15(4):187-193. PMID: 30908140.
    Citations:    
  11. Konstantinopoulos PA, Barry WT, Birrer M, Westin SN, Cadoo KA, Shapiro GI, Mayer EL, O'Cearbhaill RE, Coleman RL, Kochupurakkal B, Whalen C, Curtis J, Farooq S, Luo W, Eismann J, Buss MK, Aghajanian C, Mills GB, Palakurthi S, Kirschmeier P, Liu J, Cantley LC, Kaufmann SH, Swisher EM, D'Andrea AD, Winer E, Wulf GM, Matulonis UA. Olaparib and a-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. Lancet Oncol. 2019 Apr; 20(4):570-580. PMID: 30880072.
    Citations:    
  12. Finlay E, Rabow MW, Buss MK. Filling the Gap: Creating an Outpatient Palliative Care Program in Your Institution. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:111-121. PMID: 30231351.
    Citations:    Fields:    Translation:Humans
  13. Crousillat DR, Keeley BR, Buss MK, Zheng H, Polk DM, Schaefer KG. Palliative Care Education in Cardiology. J Am Coll Cardiol. 2018 03 27; 71(12):1391-1394. PMID: 29566823.
    Citations:    Fields:    
  14. Ramzan AA, Fischer S, Buss MK, Urban RR, Patsner B, Duska LR, Fisher CM, Lefkowits C. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility. Gynecol Oncol. 2018 05; 149(2):401-409. PMID: 29544707.
    Citations:    Fields:    Translation:HumansPHPublic Health
  15. Lefkowits C, Buss MK, Ramzan AA, Fischer S, Urban RR, Fisher CM, Duska LR. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review. Gynecol Oncol. 2018 05; 149(2):394-400. PMID: 29472016.
    Citations:    Fields:    Translation:HumansPHPublic Health
  16. Maggiore RJ, Dale W, Hurria A, Klepin HD, Chapman A, Dotan E, Mohile SG, Naeim A, Gajra A, Buss MK. Hematology-Oncology Fellows' Training in Geriatrics and Geriatric Oncology: Findings From an American Society of Clinical Oncology-Sponsored National Survey. J Oncol Pract. 2017 11; 13(11):e900-e908. PMID: 28837375.
    Citations:    Fields:    Translation:Humans
  17. Buss MK. The Intersection of Palliative Care and Interventional Radiology: Enhancing Understanding and Collaboration. Semin Intervent Radiol. 2017 Jun; 34(2):140-144. PMID: 28579682.
    Citations:    
  18. Einstein DJ, DeSanto-Madeya S, Gregas M, Lynch J, McDermott DF, Buss MK. Improving End-of-Life Care: Palliative Care Embedded in an Oncology Clinic Specializing in Targeted and Immune-Based Therapies. J Oncol Pract. 2017 09; 13(9):e729-e737. PMID: 28562197.
    Citations: 1     Fields:    Translation:Humans
  19. Zerillo JA, Schouwenburg MG, van Bommel ACM, Stowell C, Lippa J, Bauer D, Berger AM, Boland G, Borras JM, Buss MK, Cima R, Van Cutsem E, van Duyn EB, Finlayson SRG, Hung-Chun Cheng S, Langelotz C, Lloyd J, Lynch AC, Mamon HJ, McAllister PK, Minsky BD, Ngeow J, Abu Hassan MR, Ryan K, Shankaran V, Upton MP, Zalcberg J, van de Velde CJ, Tollenaar R. An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer. JAMA Oncol. 2017 May 01; 3(5):686-694. PMID: 28384684.
    Citations: 2     Fields:    Translation:Humans
  20. DeSanto-Madeya S, McDermott D, Zerillo JA, Weinstein N, Buss MK. Developing a model for embedded palliative care in a cancer clinic. BMJ Support Palliat Care. 2017 Sep; 7(3):247-250. PMID: 28258162.
    Citations:    Fields:    Translation:Humans
  21. Buss MK, Rock LK, McCarthy EP. Understanding Palliative Care and Hospice: A Review for Primary Care Providers. Mayo Clin Proc. 2017 02; 92(2):280-286. PMID: 28160875.
    Citations:    Fields:    Translation:Humans
  22. Bickel KE, McNiff K, Buss MK, Kamal A, Lupu D, Abernethy AP, Broder MS, Shapiro CL, Acheson AK, Malin J, Evans T, Krzyzanowska MK. Defining High-Quality Palliative Care in Oncology Practice: An American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance Statement. J Oncol Pract. 2016 09; 12(9):e828-38. PMID: 27531376.
    Citations: 10     Fields:    Translation:Humans
  23. Hui D, Finlay E, Buss MK, Prommer E, Bruera E. Reply to J.M. Snaman et al. J Clin Oncol. 2016 Jan 20; 34(3):289. PMID: 26598754.
    Citations:    Fields:    Translation:Humans
  24. Binder AF, Huang GC, Buss MK. Uninformed consent: Do medicine residents lack the proper framework for code status discussions? J Hosp Med. 2016 Feb; 11(2):111-6. PMID: 26471452.
    Citations: 1     Fields:    Translation:Humans
  25. DeSanto-Madeya S, Zerillo JA, Gregas M, McDermott DF, Mukamal KJ, Buss MK. Impact of integrated palliative care model on end-of-life (EOL) quality metrics for patients with kidney cancer (RCC) and melanoma (M). J Clin Oncol. 2015 Oct 10; 33(29_suppl):137. PMID: 28148066.
    Citations:    
  26. McNiff KK, Buss MK, Kamal A, Lupu D, Abernethy AP, Broder MS, Shapiro CL, Acheson AK, Malin J, Evans TL, Krzyzanowska MK. Defining high-quality palliative care in oncology practice: An ASCO/AAHPM Guidance Statement. J Clin Oncol. 2015 Oct 10; 33(29_suppl):108. PMID: 28148078.
    Citations:    
  27. Hui D, Finlay E, Buss MK, Prommer EE, Bruera E. Palliative Oncologists: Specialists in the Science and Art of Patient Care. J Clin Oncol. 2015 Jul 10; 33(20):2314-7. PMID: 25918292.
    Citations: 9     Fields:    Translation:Humans
  28. Potosek J, Curry M, Buss M, Chittenden E. Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med. 2014 Nov; 17(11):1271-7. PMID: 25390468.
    Citations: 13     Fields:    Translation:Humans
  29. Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel B, Buss MK, Nattam S, Hurteau J, Luo W, Quy P, Whalen C, Obermayer L, Lee H, Winer EP, Kohn EC, Ivy SP, Matulonis UA. Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study. Lancet Oncol. 2014 Oct; 15(11):1207-14. PMID: 25218906.
    Citations: 82     Fields:    Translation:HumansCTClinical Trials
  30. Barry WT, Birrer MJ, Lee JM, Buckanovich RJ, Fleming GF, Rimel B, Buss MK, Nattam SR, Hurteau J, Luo W, Quy P, Obermayer E, Whalen C, Lee H, Winer EP, Kohn EC, Ivy SP, Matulonis U. A randomized phase 2 trial comparing efficacy of the combination of the PARP inhibitor olaparib and the antiangiogenic cediranib against olaparib alone in recurrent platinum-sensitive ovarian cancer. J Clin Oncol. 2014 Jun 20; 32(18_suppl):LBA5500. PMID: 28141978.
    Citations:    
  31. Battelli C, Campo M, Buss MK, Awtrey CS, Konstantinopoulos PA. Safety and outcome of patients treated with a modified outpatient intraperitoneal regimen for epithelial ovarian, primary peritoneal or fallopian tube cancer. Chemotherapy. 2013; 59(4):251-9. PMID: 24457572.
    Citations: 1     Fields:    Translation:Humans
  32. DuBenske LL, Gustafson DH, Namkoong K, Hawkins RP, Atwood AK, Brown RL, Chih MY, McTavish F, Carmack CL, Buss MK, Govindan R, Cleary JF. CHESS improves cancer caregivers' burden and mood: results of an eHealth RCT. Health Psychol. 2014 Oct; 33(10):1261-72. PMID: 24245838.
    Citations: 20     Fields:    Translation:Humans
  33. McNiff K, Malin J, Abernethy AP, Kurup Acheson A, Shapiro CL, Evans TL, Kamal A, Buss MK, Lupu D, Broder MS, Krzyzanowska MK. Consensus development: Within general oncology practice, what constitutes high-quality palliative care delivery? J Clin Oncol. 2013 Nov; 31(31_suppl):280. PMID: 28136364.
    Citations:    
  34. Liu JF, Tolaney SM, Birrer M, Fleming GF, Buss MK, Dahlberg SE, Lee H, Whalen C, Tyburski K, Winer E, Ivy P, Matulonis UA. A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer. Eur J Cancer. 2013 Sep; 49(14):2972-8. PMID: 23810467.
    Citations: 35     Fields:    Translation:HumansCTClinical Trials
  35. Mougalian SS, Lessen DS, Levine RL, Panagopoulos G, Von Roenn JH, Arnold RM, Block SD, Buss MK. Palliative care training and associations with burnout in oncology fellows. J Support Oncol. 2013 Jun; 11(2):95-102. PMID: 23967496.
    Citations: 4     Fields:    Translation:Humans
  36. Lesnock JL, Arnold RM, Meyn LA, Buss MK, Quimper M, Krivak TC, Edwards RP, Chang JC. Palliative care education in gynecologic oncology: a survey of the fellows. Gynecol Oncol. 2013 Sep; 130(3):431-5. PMID: 23694719.
    Citations: 3     Fields:    Translation:Humans
  37. Gustafson DH, DuBenske LL, Namkoong K, Hawkins R, Chih MY, Atwood AK, Johnson R, Bhattacharya A, Carmack CL, Traynor AM, Campbell TC, Buss MK, Govindan R, Schiller JH, Cleary JF. An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trial. Cancer. 2013 May 01; 119(9):1744-51. PMID: 23355273.
    Citations: 18     Fields:    Translation:Humans
  38. Bullock AJ, Hofstatter EW, Yushak ML, Buss MK. Understanding patients' attitudes toward communication about the cost of cancer care. J Oncol Pract. 2012 Jul; 8(4):e50-8. PMID: 23180999.
    Citations: 21     Fields:    Translation:Humans
  39. Bullock AJ, Hofstatter EW, Yushak M, Buss MK. Understanding patients' attitudes toward communication about the cost of cancer care. J Clin Oncol. 2011 May 20; 29(15_suppl):6065. PMID: 28021839.
    Citations:    
  40. Buss MK, Lessen DS, Sullivan AM, Von Roenn J, Arnold RM, Block SD. Hematology/oncology fellows' training in palliative care: results of a national survey. Cancer. 2011 Sep 15; 117(18):4304-11. PMID: 21365618.
    Citations: 18     Fields:    Translation:Humans
  41. Hui D, Buss M, Saraiya B. Phase I and palliative care: the unnecessary dilemma (408) (advanced) cancer. J Pain Symptom Manage. 2011 Jan; 41(1):223. PMID: 25305908.
    Citations:    
  42. Buss MK, Lessen DS, Von Roenn J, Sullivan AM, Arnold RM, Block SD. National survey of oncology fellows on palliative care education. J Clin Oncol. 2009 May 20; 27(15_suppl):9541. PMID: 27964527.
    Citations:    
  43. Schellhorn S, Lessen DS, Levine RL, Panagopoulos G, Arnold RM, Block SD, Buss MK. Palliative care training and burnout in oncology fellows. J Clin Oncol. 2009 May 20; 27(15_suppl):9540. PMID: 27964528.
    Citations:    
  44. Cleary JF, Dubenske LL, Buss MK, Taylor CL, Atwood A, Traynor AM, Govindan R, Bhattacharya A, McTavish F, Gustafson DH. Impact of the Comprehensive Health Enhancement Support System (CHESS), an interactive computer support system (ICSS) on non small cell lung cancer (NSCLC) survival: A randomized study comparing CHESS with the internet. J Clin Oncol. 2008 May 20; 26(15_suppl):8088. PMID: 27948964.
    Citations:    
  45. Buss MK, DuBenske LL, Dinauer S, Gustafson DH, McTavish F, Cleary JF. Patient/Caregiver influences for declining participation in supportive oncology trials. J Support Oncol. 2008 Apr; 6(4):168-74. PMID: 18491685.
    Citations: 16     Fields:    Translation:Humans
  46. Buss MK, Vanderwerker LC, Inouye SK, Zhang B, Block SD, Prigerson HG. Associations between caregiver-perceived delirium in patients with cancer and generalized anxiety in their caregivers. J Palliat Med. 2007 Oct; 10(5):1083-92. PMID: 17985965.
    Citations: 11     Fields:    Translation:Humans
  47. Smith AK, Buss MK, Giansiracusa DF, Block SD. On being fired: experiences of patient-initiated termination of the patient-physician relationship in palliative medicine. J Palliat Med. 2007 Aug; 10(4):938-47. PMID: 17803417.
    Citations: 1     Fields:    Translation:Humans
  48. Temel JS, Jackson VA, Billings JA, Dahlin C, Block SD, Buss MK, Ostler P, Fidias P, Muzikansky A, Greer JA, Pirl WF, Lynch TJ. Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients. J Clin Oncol. 2007 Jun 10; 25(17):2377-82. PMID: 17557950.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  49. Buss MK, Lessen DS, Sullivan AM, Von Roenn J, Arnold RM, Block SD. A study of oncology fellows' training in end-of-life care. J Support Oncol. 2007 May; 5(5):237-42. PMID: 17564154.
    Citations: 7     Fields:    Translation:Humans
  50. Adiga K, Buss M, Beasley BW. Perceived, actual, and desired knowledge regarding Medicare billing and reimbursement. A national needs assessment survey of internal medicine residents. J Gen Intern Med. 2006 May; 21(5):466-70. PMID: 16704389.
    Citations: 6     Fields:    Translation:Humans
  51. Lessen DS, Buss MK, Panagopoulos G, Levine RL, von Roenn JH, Arnold RM, Block SD. Burnout and associated characteristics in oncology fellows. J Clin Oncol. 2005 Jun; 23(16_suppl):8168. PMID: 27947168.
    Citations:    
  52. Buss MK, Lessen DS, Sullivan AM, von Roenn JH, Arnold RM, Block SD. Survey of oncology fellows' end-of-life training. J Clin Oncol. 2005 Jun; 23(16_suppl):8032. PMID: 27946595.
    Citations:    
  53. Temel JS, Billings JA, Jackson VA, Reid C, Dahlin CM, Kornblith AB, Buss MK, Block SD, Panagiotis F, Lynch TJ. Early palliative care (PC) in advanced non-small cell lung cancer (NSCLC) is feasible. J Clin Oncol. 2005 Jun; 23(16_suppl):8070. PMID: 27946497.
    Citations:    
  54. Buss MK, Alexander GC, Switzer GE, Arnold RM. Assessing competence of residents to discuss end-of-life issues. J Palliat Med. 2005 Apr; 8(2):363-71. PMID: 15890047.
    Citations: 9     Fields:    Translation:Humans
  55. Buss MK, Arnold RM. Challenges in palliative care research: one experience. J Palliat Med. 2004 Jun; 7(3):405-7. PMID: 15265348.
    Citations: 1     Fields:    Translation:Humans
  56. Buss MK. Using a patient perspective to improve palliative education: helping patients go into that good night. J Palliat Med. 1999; 2(4):391-5. PMID: 15859779.
    Citations:    Fields:    
  57. Buss MK, Marx ES, Sulmasy DP. The preparedness of students to discuss end-of-life issues with patients. Acad Med. 1998 Apr; 73(4):418-22. PMID: 9580719.
    Citations: 10     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Buss's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (216)
Explore
_
Co-Authors (59)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.